In people with pulmonary arterial hypertension, is there randomized controlled trial evidence to support the use of endothelin receptor antagonists?

Cochrane Clinical Answers ◽

10.1002/cca.206 ◽

2013 ◽

Author(s):

William Cayley Jr

Keyword(s):

Randomized Controlled Trial ◽

Pulmonary Arterial Hypertension ◽

Arterial Hypertension ◽

Controlled Trial ◽

Endothelin Receptor Antagonists ◽

Endothelin Receptor ◽

Receptor Antagonists ◽

Randomized Controlled ◽

Pulmonary Arterial ◽

Trial Evidence

Download Full-text

Faculty Opinions recommendation of Oral treprostinil for the treatment of pulmonary arterial hypertension in patients on background endothelin receptor antagonist and/or phosphodiesterase type 5 inhibitor therapy (the FREEDOM-C study): a randomized controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717948110.793453158 ◽

2012 ◽

Author(s):

Jonathon Truwit

Keyword(s):

Randomized Controlled Trial ◽

Pulmonary Arterial Hypertension ◽

Arterial Hypertension ◽

Receptor Antagonist ◽

Controlled Trial ◽

Endothelin Receptor ◽

Randomized Controlled ◽

Phosphodiesterase Type 5 Inhibitor ◽

Pulmonary Arterial ◽

Phosphodiesterase Type

Download Full-text

Systematic Review of Randomized Controlled Trials of Endothelin Receptor Antagonists for Pulmonary Arterial Hypertension

Lung ◽

10.1007/s00408-016-9928-6 ◽

2016 ◽

Vol 194 (5) ◽

pp. 723-732 ◽

Cited By ~ 14

Author(s):

Michael Kuntz ◽

Miguel M. Leiva-Juarez ◽

Suvitesh Luthra

Keyword(s):

Systematic Review ◽

Pulmonary Arterial Hypertension ◽

Arterial Hypertension ◽

Randomized Controlled Trials ◽

Controlled Trials ◽

Endothelin Receptor Antagonists ◽

Endothelin Receptor ◽

Receptor Antagonists ◽

Randomized Controlled ◽

Pulmonary Arterial

Download Full-text

Faculty of 1000 evaluation for Oral Treprostinil for the Treatment of Pulmonary Arterial Hypertension in Patients on Background Endothelin Receptor Antagonist and/or Phosphodiesterase Type 5 Inhibitor Therapy (The FREEDOM-C2 Study): A Randomized Controlled Trial.

F1000 - Post-publication peer review of the biomedical literature ◽

10.3410/f.718016138.793479177 ◽

2013 ◽

Author(s):

Ioana Preston ◽

Nadine Al-Naamani

Keyword(s):

Randomized Controlled Trial ◽

Pulmonary Arterial Hypertension ◽

Arterial Hypertension ◽

Receptor Antagonist ◽

Controlled Trial ◽

Endothelin Receptor ◽

Randomized Controlled ◽

Phosphodiesterase Type 5 Inhibitor ◽

Pulmonary Arterial ◽

Phosphodiesterase Type

Download Full-text

Faculty Opinions recommendation of Race and sex differences in response to endothelin receptor antagonists for pulmonary arterial hypertension.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.13489110.15114060 ◽

2012 ◽

Author(s):

Robert Frantz ◽

Vivek Iyer

Keyword(s):

Sex Differences ◽

Pulmonary Arterial Hypertension ◽

Arterial Hypertension ◽

Endothelin Receptor Antagonists ◽

Endothelin Receptor ◽

Receptor Antagonists ◽

Pulmonary Arterial

Download Full-text

Endothelin receptor antagonists for pulmonary arterial hypertension

Cochrane Database of Systematic Reviews ◽

10.1002/14651858.cd004434.pub5 ◽

2013 ◽

Cited By ~ 15

Author(s):

Chao Liu ◽

Junmin Chen ◽

Yanqiu Gao ◽

Bao Deng ◽

Kunshen Liu

Keyword(s):

Pulmonary Arterial Hypertension ◽

Arterial Hypertension ◽

Endothelin Receptor Antagonists ◽

Endothelin Receptor ◽

Receptor Antagonists ◽

Pulmonary Arterial

Download Full-text

Sildenafil dosed concomitantly with bosentan for adult pulmonary arterial hypertension in a randomized controlled trial

BMC Cardiovascular Disorders ◽

10.1186/s12872-017-0674-3 ◽

2017 ◽

Vol 17 (1) ◽

Cited By ~ 15

Author(s):

Carmine Dario Vizza ◽

Pavel Jansa ◽

Simon Teal ◽

Theresa Dombi ◽

Duo Zhou

Keyword(s):

Randomized Controlled Trial ◽

Pulmonary Arterial Hypertension ◽

Arterial Hypertension ◽

Controlled Trial ◽

Randomized Controlled ◽

Pulmonary Arterial

Download Full-text

Endothelin Receptor Antagonists for the Treatment of Pulmonary Arterial Hypertension

Textbook of Pulmonary Vascular Disease ◽

10.1007/978-0-387-87429-6_105 ◽

2010 ◽

pp. 1465-1475

Author(s):

Victor F. Tapson ◽

Robyn J. Barst

Keyword(s):

Pulmonary Arterial Hypertension ◽

Arterial Hypertension ◽

Endothelin Receptor Antagonists ◽

Endothelin Receptor ◽

Receptor Antagonists ◽

Pulmonary Arterial

Download Full-text

Non-invasive Evaluation Of The Effects Of Endothelin Receptor Antagonists On Pulmonary Blood Flow In Patients With Pulmonary Arterial Hypertension At Rest And Under Exercise

10.1164/ajrccm-conference.2010.181.1_meetingabstracts.a6833 ◽

2010 ◽

Author(s):

Susanna Desole ◽

Peter H. Heininger ◽

Claudia Seemann ◽

Silvana Müller ◽

Renate Hiemetzberger ◽

...

Keyword(s):

Blood Flow ◽

Pulmonary Arterial Hypertension ◽

Arterial Hypertension ◽

Pulmonary Blood Flow ◽

Endothelin Receptor Antagonists ◽

Endothelin Receptor ◽

Receptor Antagonists ◽

Non Invasive ◽

Pulmonary Arterial ◽

Invasive Evaluation

Download Full-text

Reduction Of Pulmonary Arterial Hypertension (Pah)-Related Hospitalizations With Macitentan In The Randomized Controlled Trial Seraphin

Value in Health ◽

10.1016/j.jval.2013.03.1175 ◽

2013 ◽

Vol 16 (3) ◽

pp. A231 ◽

Cited By ~ 2

Author(s):

R.N. Channick ◽

M. Delcroix ◽

N. Galiè ◽

H.A. Ghofrani ◽

E. Hunsche ◽

...

Keyword(s):

Randomized Controlled Trial ◽

Pulmonary Arterial Hypertension ◽

Arterial Hypertension ◽

Controlled Trial ◽

Randomized Controlled ◽

Pulmonary Arterial

Download Full-text

Drug Insight: endothelin-receptor antagonists for pulmonary arterial hypertension in systemic rheumatic diseases

Nature Clinical Practice Rheumatology ◽

10.1038/ncprheum0048 ◽

2005 ◽

Vol 1 (2) ◽

pp. 93-101 ◽

Cited By ~ 11

Author(s):

Marc Humbert ◽

Gérald Simonneau

Keyword(s):

Pulmonary Arterial Hypertension ◽

Arterial Hypertension ◽

Rheumatic Diseases ◽

Endothelin Receptor Antagonists ◽

Endothelin Receptor ◽

Receptor Antagonists ◽

Systemic Rheumatic Diseases ◽

Pulmonary Arterial

Download Full-text